JSPR
Jasper Therapeutics, Inc.Company with tickers: JSPR, JSPRW
CIK
1788028
CUSIP
471871202
Shares Outstanding
27,996,819
Website
https://jaspertx.com
13F Activity (30d)
5 filings
4 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Ronald Martell | CEO | $2,494,099 |
| Edwin Tucker | — | $1,537,032 |
| Jeet Mahal | CEO | $1,289,599 |
| Herb Cross | CFO | $1,283,474 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Ronald Martell | CEO | $3,215,003 |
| Edwin Tucker | — | $1,400,620 |
| Jeet Mahal | CEO | $1,278,131 |
| Herb Cross | CFO | $1,270,940 |